Literature DB >> 7686253

Identification of an alternate promoter in the rat androgen-binding protein/sex hormone-binding globulin gene that regulates synthesis of a messenger RNA encoding a protein with altered function.

P M Sullivan1, Y M Wang, D R Joseph.   

Abstract

Extracellular androgen-binding proteins (ABP) are thought to modulate the regulatory functions of androgens. These proteins, which are secreted by the testis (ABP) and liver [sex hormone-binding globulin (SHBG)], are encoded by the same gene. In a previous study, the rat ABP/SHBG gene was sequenced, and a promoter (P1) was identified by primer extension. This promoter regulates synthesis of the mRNA that encodes secreted testicular ABP and fetal liver SHBG. In this study, the P1 transcriptional start site in testis and fetal liver was confirmed by RNase protection assays. We also identified an alternate promoter (PA) in the ABP/SHBG gene located 15 kilobases up-stream from the previously characterized testicular promoter (P1). The PA region has the characteristics of a GC-rich housekeeping-type promoter. RNAase protection and primer walking experiments with RNA polymerase chain reaction identified a region where the major sites of transcription initiation occur. Promoter PA directs the synthesis of alternate ABP RNAs, which contain an alternate exon 1 (exon A) sequence. One alternate ABP RNA, which contains exons A and 2-8 sequences, is expressed in testis, fetal liver, and brain. This alternate ABP RNA encodes an ABP-like protein (46,000 daltons) with an altered N-terminal sequence without a secretory signal peptide. Expression of the ABP-like protein in COS cells revealed that it is not secreted and does not appear to bind dihydrotestosterone. Another similar alternate ABP RNA is missing exon 6 sequence and encodes a nonsecretory truncated protein (28,000 daltons) that does not bind androgen. The functions of the ABP-like proteins are not obvious, but their functions are clearly different from secreted ABP and SHBG.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686253     DOI: 10.1210/mend.7.5.7686253

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

Authors:  Y H Choi; D Ekholm; J Krall; F Ahmad; E Degerman; V C Manganiello; M A Movsesian
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

Review 2.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

3.  NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2).

Authors:  Lata Mahishi; Karen Usdin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

4.  Initiation binding repressor, a factor that binds to the transcription initiation site of the histone h5 gene, is a glycosylated member of a family of cell growth regulators [corrected].

Authors:  A Gómez-Cuadrado; M Martín; M Noël; A Ruiz-Carrillo
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis.

Authors:  P G Zaphiropoulos
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 6.  Testosterone Retention Mechanism in Sertoli Cells: A Biochemical Perspective.

Authors:  Manjeet Kaur Gill-Sharma
Journal:  Open Biochem J       Date:  2018-06-29

7.  Human sex hormone-binding globulin gene expression- multiple promoters and complex alternative splicing.

Authors:  Atif M Nakhla; Daniel J Hryb; William Rosner; Nicholas A Romas; Zhaoying Xiang; Scott M Kahn
Journal:  BMC Mol Biol       Date:  2009-05-05       Impact factor: 2.946

Review 8.  Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men.

Authors:  Carla Basualto-Alarcón; Paola Llanos; Gerardo García-Rivas; Mayarling Francisca Troncoso; Daniel Lagos; Genaro Barrientos; Manuel Estrada
Journal:  Int J Endocrinol       Date:  2021-07-21       Impact factor: 2.803

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.